U S PHYSICAL THERAPY INC /NV Proceeds from Lines of Credit
U S PHYSICAL THERAPY INC /NV (USPH) reported Proceeds from Lines of Credit of $153.26 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-08-07
- U S PHYSICAL THERAPY INC /NV proceeds from lines of credit for the quarter ending 2026-06-30 was $76.26M, a 34.98% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV proceeds from lines of credit for the quarter ending 2026-03-31 was $77.00M, a 352.94% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV proceeds from lines of credit for the quarter ending 2025-12-31 was $43.00M, a 126.32% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV proceeds from lines of credit for the quarter ending 2025-09-30 was $73.00M.
- U S PHYSICAL THERAPY INC /NV proceeds from lines of credit for fiscal 2025 was $189.50M, a 897.37% increase from fiscal 2024.
- U S PHYSICAL THERAPY INC /NV proceeds from lines of credit for fiscal 2024 was $19.00M, a 20.83% decline from fiscal 2023.
- U S PHYSICAL THERAPY INC /NV proceeds from lines of credit for fiscal 2023 was $24.00M, a 76.24% decline from fiscal 2022.
- U S PHYSICAL THERAPY INC /NV proceeds from lines of credit for fiscal 2022 was $101.00M, a 68.04% decline from fiscal 2021.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $76.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $153.26M 10-Q · filed 2026-08-07 | $196.26M derived: sum of 3 quarters · filed 2026-08-07 | $269.26M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $77.00M 10-Q · filed 2026-05-08 | $120.00M derived: sum of 2 quarters · filed 2026-05-08 | $193.00M derived: sum of 3 quarters · filed 2026-05-08 | $249.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $116.00M derived: sum of 2 quarters · filed 2026-02-27 | $172.50M derived: sum of 3 quarters · filed 2026-08-07 | $189.50M 10-K · filed 2026-02-27 |
| 2025-09-30 | $73.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $129.50M derived: sum of 2 quarters · filed 2026-08-07 | $146.50M 10-Q · filed 2025-11-07 | $165.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $56.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $73.50M 10-Q · filed 2026-08-07 | $92.50M derived: sum of 3 quarters · filed 2026-08-07 | $92.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $17.00M 10-Q · filed 2026-05-08 | $36.00M derived: sum of 2 quarters · filed 2026-05-08 | $36.00M derived: sum of 3 quarters · filed 2026-05-08 | $36.00M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $19.00M derived: sum of 2 quarters · filed 2026-02-27 | $19.00M derived: sum of 3 quarters · filed 2026-02-27 | $19.00M 10-K · filed 2026-02-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | $0.00 derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | $0.00 derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | $17.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $17.00M derived: sum of 3 quarters · filed 2026-02-27 | $24.00M 10-K · filed 2026-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $17.00M derived: sum of 2 quarters · filed 2024-11-08 | $24.00M 10-Q · filed 2024-11-08 | $64.00M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $17.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $24.00M 10-Q · filed 2024-08-14 | $64.00M derived: sum of 3 quarters · filed 2025-03-03 | $64.00M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $7.00M 10-Q · filed 2024-05-08 | $47.00M derived: sum of 2 quarters · filed 2025-03-03 | $47.00M derived: sum of 3 quarters · filed 2025-03-03 | $73.00M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $40.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $40.00M derived: sum of 2 quarters · filed 2025-03-03 | $66.00M derived: sum of 3 quarters · filed 2025-03-03 | $101.00M 10-K · filed 2025-03-03 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $26.00M derived: sum of 2 quarters · filed 2023-11-08 | $61.00M 10-Q · filed 2023-11-08 | $184.00M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $26.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $61.00M 10-Q · filed 2023-08-09 | $184.00M derived: sum of 3 quarters · filed 2024-02-29 | $249.00M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $35.00M 10-Q · filed 2023-05-05 | $158.00M derived: sum of 2 quarters · filed 2024-02-29 | $223.00M derived: sum of 3 quarters · filed 2024-02-29 | $291.00M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $123.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $188.00M derived: sum of 2 quarters · filed 2024-02-29 | $256.00M derived: sum of 3 quarters · filed 2024-02-29 | $316.00M 10-K · filed 2024-02-29 |
| 2021-09-30 | $65.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $133.00M derived: sum of 2 quarters · filed 2022-11-08 | $193.00M 10-Q · filed 2022-11-08 | $273.00M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $68.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $128.00M 10-Q · filed 2022-08-08 | $208.00M derived: sum of 3 quarters · filed 2023-02-28 | $243.00M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $60.00M 10-Q · filed 2022-05-09 | $140.00M derived: sum of 2 quarters · filed 2023-02-28 | $175.00M derived: sum of 3 quarters · filed 2023-02-28 | $186.00M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $80.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $115.00M derived: sum of 2 quarters · filed 2023-02-28 | $126.00M derived: sum of 3 quarters · filed 2023-02-28 | $214.00M 10-K · filed 2023-02-28 |
| 2020-09-30 | $35.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $46.00M derived: sum of 2 quarters · filed 2021-11-09 | $134.00M 10-Q · filed 2021-11-09 | $169.00M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $11.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $99.00M 10-Q · filed 2021-08-09 | $134.00M derived: sum of 3 quarters · filed 2022-03-01 | $164.00M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $88.00M 10-Q · filed 2021-05-10 | $123.00M derived: sum of 2 quarters · filed 2022-03-01 | $153.00M derived: sum of 3 quarters · filed 2022-03-01 | $214.00M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $35.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $65.00M derived: sum of 2 quarters · filed 2022-03-01 | $126.00M derived: sum of 3 quarters · filed 2022-03-01 | $145.00M 10-K · filed 2022-03-01 |
| 2019-09-30 | $30.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $91.00M derived: sum of 2 quarters · filed 2020-11-06 | $110.00M 10-Q · filed 2020-11-06 | $134.00M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $61.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $80.00M 10-Q · filed 2020-08-07 | $104.00M derived: sum of 3 quarters · filed 2021-03-01 | $128.00M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $19.00M 10-Q · filed 2020-05-21 | $43.00M derived: sum of 2 quarters · filed 2021-03-01 | $67.00M derived: sum of 3 quarters · filed 2021-03-01 | $103.00M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $48.00M derived: sum of 2 quarters · filed 2021-03-01 | $84.00M derived: sum of 3 quarters · filed 2021-03-01 | $103.00M 10-K · filed 2021-03-01 |
| 2018-09-30 | $24.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $60.00M derived: sum of 2 quarters · filed 2019-11-08 | $79.00M 10-Q · filed 2019-11-08 | $109.00M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $36.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $55.00M 10-Q · filed 2019-08-09 | $85.00M derived: sum of 3 quarters · filed 2020-02-28 | $99.00M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $19.00M 10-Q · filed 2019-05-06 | $49.00M derived: sum of 2 quarters · filed 2020-02-28 | $63.00M derived: sum of 3 quarters · filed 2020-02-28 | $80.00M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $30.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $44.00M derived: sum of 2 quarters · filed 2020-02-28 | $61.00M derived: sum of 3 quarters · filed 2020-02-28 | $93.00M 10-K · filed 2020-02-28 |
| 2017-09-30 | $14.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $31.00M derived: sum of 2 quarters · filed 2018-11-07 | $63.00M 10-Q · filed 2018-11-07 | $103.00M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | $17.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $49.00M 10-Q · filed 2018-08-07 | $89.00M derived: sum of 3 quarters · filed 2019-03-18 | $124.00M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | $32.00M 10-Q · filed 2018-05-07 | $72.00M derived: sum of 2 quarters · filed 2019-03-18 | $107.00M derived: sum of 3 quarters · filed 2019-03-18 | $151.00M derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | $40.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $75.00M derived: sum of 2 quarters · filed 2019-03-18 | $119.00M derived: sum of 3 quarters · filed 2019-03-18 | $168.00M 10-K · filed 2019-03-18 |
| 2016-09-30 | $35.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $79.00M derived: sum of 2 quarters · filed 2017-11-07 | $128.00M 10-Q · filed 2017-11-07 | $156.00M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $44.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $93.00M 10-Q · filed 2017-08-07 | $121.00M derived: sum of 3 quarters · filed 2018-03-14 | $145.00M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $49.00M 10-Q · filed 2017-06-29 | $77.00M derived: sum of 2 quarters · filed 2018-03-14 | $101.00M derived: sum of 3 quarters · filed 2018-03-14 | $118.00M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $28.00M derived: 10-K 12 month − 10-K 9 month · filed 2018-03-14 | $52.00M derived: sum of 2 quarters · filed 2018-03-14 | $69.00M derived: sum of 3 quarters · filed 2018-03-14 | $103.00M 10-K · filed 2018-03-14 |
| 2015-09-30 | $24.00M derived: 10-K 9 month − 10-K 6 month · filed 2017-06-07 | $41.00M derived: sum of 2 quarters · filed 2017-06-07 | $75.00M 10-K · filed 2017-06-07 | $97.00M derived: sum of 4 quarters · filed 2017-06-07 |
| 2015-06-30 | $17.00M derived: 10-K 6 month − 10-K 3 month · filed 2017-06-07 | $51.00M 10-K · filed 2017-06-07 | $73.00M derived: sum of 3 quarters · filed 2017-06-07 | $108.30M derived: sum of 4 quarters · filed 2017-06-07 |
| 2015-03-31 | $34.00M 10-K · filed 2017-06-07 | $56.00M derived: sum of 2 quarters · filed 2017-06-07 | $91.30M derived: sum of 3 quarters · filed 2017-06-07 | $139.30M derived: sum of 4 quarters · filed 2017-06-07 |
| 2014-12-31 | $22.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-07 | $57.30M derived: sum of 2 quarters · filed 2017-06-07 | $105.30M derived: sum of 3 quarters · filed 2017-06-07 | $134.30M 10-K · filed 2017-06-07 |
| 2014-09-30 | $35.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $83.30M derived: sum of 2 quarters · filed 2015-11-05 | $112.30M 10-Q · filed 2015-11-05 | $174.65M derived: sum of 4 quarters · filed 2016-03-04 |
| 2014-06-30 | $48.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $77.00M 10-Q · filed 2015-08-06 | $139.35M derived: sum of 3 quarters · filed 2016-03-04 | $165.25M derived: sum of 4 quarters · filed 2016-03-04 |
| 2014-03-31 | $29.00M 10-Q · filed 2015-05-07 | $91.35M derived: sum of 2 quarters · filed 2016-03-04 | $117.25M derived: sum of 3 quarters · filed 2016-03-04 | $149.20M derived: sum of 4 quarters · filed 2016-03-04 |
| 2013-12-31 | $62.35M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | $88.25M derived: sum of 2 quarters · filed 2016-03-04 | $120.20M derived: sum of 3 quarters · filed 2016-03-04 | $150.80M 10-K · filed 2016-03-04 |
| 2013-09-30 | $25.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $57.85M derived: sum of 2 quarters · filed 2014-11-07 | $88.45M 10-Q · filed 2014-11-07 | $112.45M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $31.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $62.55M 10-Q · filed 2014-08-07 | $86.55M derived: sum of 3 quarters · filed 2015-03-12 | $110.05M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $30.60M 10-Q · filed 2014-05-09 | $54.60M derived: sum of 2 quarters · filed 2015-03-12 | $78.10M derived: sum of 3 quarters · filed 2015-03-12 | $102.10M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $47.50M derived: sum of 2 quarters · filed 2015-03-12 | $71.50M derived: sum of 3 quarters · filed 2015-03-12 | $79.90M 10-K · filed 2015-03-12 |
| 2012-09-30 | $23.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $47.50M derived: sum of 2 quarters · filed 2013-11-07 | $55.90M 10-Q · filed 2013-11-07 | $80.80M derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-06-30 | $24.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $32.40M 10-Q · filed 2013-08-08 | $57.30M derived: sum of 3 quarters · filed 2014-03-11 | $109.00M derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-03-31 | $8.40M 10-Q · filed 2013-05-09 | $33.30M derived: sum of 2 quarters · filed 2014-03-11 | $85.00M derived: sum of 3 quarters · filed 2014-03-11 | $123.30M derived: sum of 4 quarters · filed 2014-03-11 |
| 2011-12-31 | $24.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $76.60M derived: sum of 2 quarters · filed 2014-03-11 | $114.90M derived: sum of 3 quarters · filed 2014-03-11 | $118.90M 10-K · filed 2014-03-11 |
| 2011-09-30 | $51.70M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-09 | $90.00M derived: sum of 2 quarters · filed 2012-11-09 | $94.00M 10-Q · filed 2012-11-09 | $103.50M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-06-30 | $38.30M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-06 | $42.30M 10-Q/A · filed 2012-09-06 | $51.80M derived: sum of 3 quarters · filed 2013-03-12 | $60.80M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-03-31 | $4.00M 10-Q · filed 2012-05-04 | $13.50M derived: sum of 2 quarters · filed 2013-03-12 | $22.50M derived: sum of 3 quarters · filed 2013-03-12 | |
| 2010-12-31 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $18.50M derived: sum of 2 quarters · filed 2013-03-12 | $46.30M 10-K · filed 2013-03-12 | |
| 2010-09-30 | $9.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $36.80M 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | $27.80M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $24.45M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |